Article
Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity.
European journal of clinical pharmacology - 1 Dec 2005
Fukasawa T, Yasui-Furukori N, Suzuki A, Inoue Y, Tateishi T, Otani K
Abstract excerpt
OBJECTIVE: To examine the effect of cytochrome P450 (CYP) 2C19 activity on the single-dose pharmacokinetics and pharmacodynamics of etizolam. METHODS: The subjects were 21 healthy Japanese volunteers. The two mutated alleles (CYP2C19*2 and CYP2C19*3) causing absent CYP2C19 activity were identified by a polymerase chain reaction method. Twelve subjects were extensive metabolizers (EMs) with no or one mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
